MLLCF
Price
$3.50
Change
+$0.05 (+1.45%)
Updated
Sep 17 closing price
Capitalization
135.23M
VICP
Price
$1.77
Change
+$0.50 (+39.37%)
Updated
Mar 24 closing price
Capitalization
57.3M
Interact to see
Advertisement

MLLCF vs VICP

Header iconMLLCF vs VICP Comparison
Open Charts MLLCF vs VICPBanner chart's image
Molecular Partners AG
Price$3.50
Change+$0.05 (+1.45%)
Volume$190
Capitalization135.23M
Vicapsys Life Sciences
Price$1.77
Change+$0.50 (+39.37%)
Volume$100
Capitalization57.3M
MLLCF vs VICP Comparison Chart in %
Loading...
MLLCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLLCF vs. VICP commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLLCF is a Hold and VICP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (MLLCF: $3.50 vs. VICP: $1.77)
Brand notoriety: MLLCF and VICP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLLCF: 17% vs. VICP: 100%
Market capitalization -- MLLCF: $135.23M vs. VICP: $57.3M
MLLCF [@Biotechnology] is valued at $135.23M. VICP’s [@Biotechnology] market capitalization is $57.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLLCF’s FA Score shows that 0 FA rating(s) are green whileVICP’s FA Score has 1 green FA rating(s).

  • MLLCF’s FA Score: 0 green, 5 red.
  • VICP’s FA Score: 1 green, 4 red.
According to our system of comparison, both MLLCF and VICP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLLCF’s TA Score shows that 2 TA indicator(s) are bullish.

  • MLLCF’s TA Score: 2 bullish, 4 bearish.

Price Growth

MLLCF (@Biotechnology) experienced а +1.45% price change this week, while VICP (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was +10.70%, and the average quarterly price growth was +54.52%.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLLCF($135M) has a higher market cap than VICP($57.3M). MLLCF YTD gains are higher at: -14.842 vs. VICP (-74.714).
MLLCFVICPMLLCF / VICP
Capitalization135M57.3M236%
EBITDA-62.52MN/A-
Gain YTD-14.842-74.71420%
P/E RatioN/AN/A-
Revenue681KN/A-
Total Cash114MN/A-
Total Debt1.84MN/A-
FUNDAMENTALS RATINGS
MLLCF vs VICP: Fundamental Ratings
MLLCF
VICP
OUTLOOK RATING
1..100
9735
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
1
Undervalued
PROFIT vs RISK RATING
1..100
10094
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
8981
P/E GROWTH RATING
1..100
84100
SEASONALITY SCORE
1..100
5055

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VICP's Valuation (1) in the null industry is somewhat better than the same rating for MLLCF (44). This means that VICP’s stock grew somewhat faster than MLLCF’s over the last 12 months.

VICP's Profit vs Risk Rating (94) in the null industry is in the same range as MLLCF (100). This means that VICP’s stock grew similarly to MLLCF’s over the last 12 months.

MLLCF's SMR Rating (98) in the null industry is in the same range as VICP (100). This means that MLLCF’s stock grew similarly to VICP’s over the last 12 months.

VICP's Price Growth Rating (81) in the null industry is in the same range as MLLCF (89). This means that VICP’s stock grew similarly to MLLCF’s over the last 12 months.

MLLCF's P/E Growth Rating (84) in the null industry is in the same range as VICP (100). This means that MLLCF’s stock grew similarly to VICP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MLLCFVICP
RSI
ODDS (%)
Bullish Trend 2 days ago
50%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
45%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
63%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
50%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
45%
Bullish Trend 2 days ago
17%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
15%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MLLCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASGOF1.750.15
+9.37%
Asante Gold Corp
RGLXY4.08N/A
N/A
RTL Group SA
DBOEY26.09-0.36
-1.36%
Deutsche Boerse AG
CMRB4.70-0.09
-1.78%
First Commerce Bancorp Inc.
MBCOF0.16-0.01
-7.54%
MARVEL BIOSCIENCES CORP.

MLLCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLLCF has been loosely correlated with ENSC. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MLLCF jumps, then ENSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLLCF
1D Price
Change %
MLLCF100%
N/A
ENSC - MLLCF
40%
Loosely correlated
-2.74%
HNSBF - MLLCF
28%
Poorly correlated
N/A
VICP - MLLCF
28%
Poorly correlated
N/A
GNPX - MLLCF
26%
Poorly correlated
-4.26%
KALA - MLLCF
23%
Poorly correlated
-8.89%
More

VICP and

Correlation & Price change

A.I.dvisor indicates that over the last year, VICP has been loosely correlated with DMAC. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if VICP jumps, then DMAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VICP
1D Price
Change %
VICP100%
N/A
DMAC - VICP
33%
Loosely correlated
-1.72%
GOVX - VICP
31%
Poorly correlated
-1.19%
KALA - VICP
29%
Poorly correlated
-8.89%
CASI - VICP
29%
Poorly correlated
-8.98%
ZLDPF - VICP
28%
Poorly correlated
N/A
More